Abstract

Cervical cancer is the fourth most common malignancy in women worldwide, although it is preventable with prophylactic HPV vaccination. HPV transmission-dynamic models can predict the potential for the global elimination of cervical cancer. The random network model is a new approach that allows individuals to be followed, and to implement a given vaccination policy according to their clinical records. We developed an HPV transmission-dynamic model on a lifetime sexual partners network based on individual contacts, also accounting for the sexual behavior of men who have sex with men (MSM). We analyzed the decline in the prevalence of HPV infection in a scenario of 75% and 90% coverage for both sexes. An important herd immunity effect for men and women was observed in the heterosexual network, even with 75% coverage. However, HPV infections are persistent in the MSM population, with sustained circulation of the virus among unvaccinated individuals. Coverage around 75% of both sexes would be necessary to eliminate HPV-related conditions in women within five decades. Nevertheless, the variation in the decline in infection in the long term between a vaccination coverage of 75% and 90% is relatively small, suggesting that reaching coverage of around 70–75% in the heterosexual network may be enough to confer high protection. Nevertheless, HPV elimination may be achieved if men’s coverage is strictly controlled. This accurate representation of HPV transmission demonstrates the need to maintain high HPV vaccination coverage, especially in men, for whom the cost-effectiveness of vaccination is questioned.

Highlights

  • Cervical cancer is the fourth most common malignancy in women worldwide, but through vaccination with the human papillomavirus (HPV) vaccine and screening with cervical smear tests, it is a preventable disease [1]

  • In order to understand whether achieving elimination is possible, academic groups commissioned by the Secretariat have modeled the epidemiology of HPV infection and cancer, and the efficacy of HPV vaccination strategies, screening, and treatment [2]

  • Our results suggest that health equity for men who have sex with men (MSM) compared to heterosexuals for HPV

Read more

Summary

Introduction

Cervical cancer is the fourth most common malignancy in women worldwide, but through vaccination with the human papillomavirus (HPV) vaccine and screening with cervical smear tests, it is a preventable disease [1]. All mathematical models have predicted that vaccinating girls against HPV is strongly cost-effective [3], but the same cannot be concluded for vaccinating boys [4,5]. Brisson et al [6], in a systematic review and meta-analysis of model predictions, concluded that the elimination of oncogenic HPV genotypes included in the quadrivalent vaccine will be reached after 80 years of vaccinating boys and girls with a coverage of 80%. Simms et al [7], using a dynamic mathematical model, postulated that 80–100% vaccine coverage with a nine-valent vaccine in girls only combined with HPV-based screening twice per lifetime with 70% uptake could reduce the worldwide mean age-adjusted cervical cancer incidence to less than 4 per 100,000 women in the years between 2020 and

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call